Topic: Pets Choice Limited

Pets Choice Limited has established a veterinary division to develop a range of cannabidiol (CBD) oral dosage formats capable of being prescribed under the cascade.

The new division has been granted a ManSA license by the Veterinary Medicines Directorate (VMD).

Glesni Owen, Head of Veterinary Sales, said: “Veterinary professionals across the world increasingly prescribing CBD products to their patients for a variety of health conditions including osteoarthritis, epilepsy, pain management and a variety of other behavioural issues.

“Research into the use of CBD is advancing daily which provides veterinary professionals with an increased knowledge base to help clients make informed decisions about treating their pets.”

Pets Choice have been working closely with veterinary professionals in the United States where CBD therapy is far more widely prescribed, collating and sharing the latest supporting evidence and guidance for vets here in the UK to feel comfortable discussing it with their clients. 

Glesni said: “We have developed a CPD-accredited educational webinar and also recorded a podcast with the Vet Times, interviewing highly-respected US-based veterinarian Jeffrey Powers, who has extensive experience prescribing CBD to his patients.” 

https://petschoice-2.wistia.com/medias/cn1g7dr2rc 

For further information, contact specials@petschoice.co.uk or 01934 831000.